| ISIN | CH0304614131 |
|---|---|
| Valor Number | 30461413 |
| Bloomberg Global ID | |
| Fund Name | BEKB Aktien Schweiz A |
| Fund Provider |
Berner Kantonalbank AG
Bern, Switzerland Phone: +41 31 666 11 11 E-Mail: bekb@bekb.ch Web: www.bekb.ch/fonds |
| Fund Provider | Berner Kantonalbank AG |
| Representative in Switzerland | |
| Distributor(s) |
Berner Kantonalbank Bern Phone: +41 31 666 11 11 |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Distribution |
| Home Country | Switzerland |
| Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
| Redemption Condition | The fund charges a transaction fee (contribution towards covering expenses incurred in the sale of assets) |
| Investment Strategy *** | N/A |
| Peculiarities |
| Current Price * | 140.85 CHF | 18.12.2025 |
|---|---|---|
| Previous Price * | 139.57 CHF | 17.12.2025 |
| 52 Week High * | 140.85 CHF | 18.12.2025 |
| 52 Week Low * | 115.27 CHF | 09.04.2025 |
| NAV * | 140.85 CHF | 18.12.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 573,810,489 | |
| Unit/Share Assets *** | 79,445,795 | |
| Trading Information SIX | ||
| YTD Performance | +14.09% |
31.12.2024 - 18.12.2025
31.12.2024 18.12.2025 |
|---|---|---|
| 1 month | +5.42% |
18.11.2025 - 18.12.2025
18.11.2025 18.12.2025 |
| 3 months | +6.70% |
18.09.2025 - 18.12.2025
18.09.2025 18.12.2025 |
| 6 months | +7.69% |
18.06.2025 - 18.12.2025
18.06.2025 18.12.2025 |
| 1 year | +13.47% |
18.12.2024 - 18.12.2025
18.12.2024 18.12.2025 |
| 2 years | +19.25% |
18.12.2023 - 18.12.2025
18.12.2023 18.12.2025 |
| 3 years | +28.61% |
19.12.2022 - 18.12.2025
19.12.2022 18.12.2025 |
| 5 years | +30.54% |
18.12.2020 - 18.12.2025
18.12.2020 18.12.2025 |
| Equity Participation Rate in % | 98.52 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Roche Holding AG | 13.37% | |
|---|---|---|
| Novartis AG Registered Shares | 13.26% | |
| Nestle SA | 12.76% | |
| UBS Group AG Registered Shares | 6.03% | |
| ABB Ltd | 6.00% | |
| Zurich Insurance Group AG | 4.96% | |
| Compagnie Financiere Richemont SA Class A | 3.88% | |
| Lonza Group Ltd | 2.86% | |
| Givaudan SA | 2.64% | |
| Sika AG | 2.36% | |
| Last data update | 30.11.2025 | |
| TER | 1.10% |
|---|---|
| TER date | 30.08.2024 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 2.00% |
| Ongoing Charges *** | |
|
SRRI ***
|
|
| SRRI date *** | 30.11.2025 |